AMERICAN INTERNATIONAL GROUP, INC. - PHATHOM PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 59 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.5%.

Links
Filings
External links
Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of PHATHOM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$159,791
-5.8%
15,409
+30.1%
0.00%0.0%
Q2 2023$169,635
+100.7%
11,846
+0.1%
0.00%0.0%
Q1 2023$84,538
-35.1%
11,840
+2.0%
0.00%0.0%
Q4 2022$130,197
+7.6%
11,604
+6.1%
0.00%0.0%
Q3 2022$121,000
+33.0%
10,933
+1.4%
0.00%0.0%
Q2 2022$91,000
-33.6%
10,778
+7.2%
0.00%0.0%
Q1 2022$137,000
-35.4%
10,055
-6.6%
0.00%0.0%
Q4 2021$212,000
-40.4%
10,763
-2.9%
0.00%
-50.0%
Q3 2021$356,000
-7.3%
11,085
-2.3%
0.00%
+100.0%
Q2 2021$384,000
+51.8%
11,348
+68.2%
0.00%0.0%
Q1 2021$253,000
+22.2%
6,747
+8.0%
0.00%0.0%
Q4 2020$207,000
-12.3%
6,245
-2.8%
0.00%0.0%
Q3 2020$236,000
+9.3%
6,424
-2.2%
0.00%0.0%
Q2 2020$216,000
+31.7%
6,570
+3.1%
0.00%0.0%
Q1 2020$164,000
-21.9%
6,370
-5.5%
0.00%0.0%
Q4 2019$210,000–6,738–0.00%–
 Download
Other shareholders
PHATHOM PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 3,760,869$39,000,21212.45%
Frazier Life Sciences Management, L.P. 10,109,279$104,833,2236.96%
Decheng Capital Management III (Cayman), LLC 850,000$8,814,5002.94%
Carlyle Group Inc. 3,496,808$36,191,9631.57%
Ghost Tree Capital, LLC 395,000$4,096,1501.35%
Newtyn Management, LLC 500,000$5,185,0001.28%
Altium Capital Management LP 220,000$2,281,4001.19%
StepStone Group LP 422,085$4,377,0210.98%
MPM BioImpact LLC 347,332$3,601,8330.96%
NEA Management Company, LLC 1,276,595$12,238,2900.94%
View complete list of PHATHOM PHARMACEUTICALS INC shareholders